Publication:
Potential role of NDRG2 in reprogramming cancer metabolism and epithelial-to-mesenchymal transition

Thumbnail Image
Files
Chen-33-655-663-2018.pdf(2.42 MB)
Date
2018
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Chen, Xiang Liu ; Lei, Lan ; Hong, Lian Lian ; Ling, Zhi Qiang
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia. Departamento de Biología Celular e Histología
publication.page.editor
publication.page.department
DOI
DOI: 10.14670/HH-11-957
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Epithelial-to-mesenchymal transition (EMT) allows a cell with epithelial characteristics to transdifferentiate into a cell with mesenchymal characteristics, which is recognized as a key priming event for the initiation and evolvement of cancer metastasis. Accumulating data has shown that aberrant cancer metabolism contributes to the execution of EMT and cancer metastasis through multiple pathological pathways. Recently, the N-MYC downstream-regulated gene 2 (NDRG2), as a tumor suppressor and metabolism-related gene in various cancers, has been widely noted. NDGR2 is associated with energy metabolism, especially glycose metabolism. Hence, we propose a hypothesis that EMT is repressed by NDRG2 via cancer metabolic reprogramming, and summarize the pathological processes and molecular pathways related to the regulation of NDRG2.
publication.page.subject
NDRG2 (N-MYC downstream-regulated gene 2) , Tumor suppressor gene , EMT (Epithelial-tomesenchymal transition) , Metastasis , Metabolic reprogramming
Citation
Histology and Histopathology, Vol.33, nº7, (2018)
URI
http://hdl.handle.net/10201/119610
item.page.embargo
Collections
Histology and histopathology Vol.33, nº7 (2018)
Ir a Estadísticas